EMEA Medical Affairs Director, Evidence Strategy at Johnson & Johnson

Madrid, Community of Madrid, Spain

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Ability to evolve and lead EMEA strategic evidence generation process across the lifecycle in the Janssen pipeline
Expertise in achieving rapid, optimal market access and differentiation versus competitor medicines
Capability to oversee input into redesign and coordinate implementation of best-in-class end-to-end evidence generation strategy for EMEA on Medical and Access aspects
Based in EMEA (locations: Beerse, Antwerp, Belgium; Breda, Netherlands; Diegem, Flemish Brabant, Belgium; Espoo, Uusimaa, Finland; Issy-les-Moulineaux, France; Madrid, Spain; Milano, Italy; Neuss, North Rhine-Westphalia, Germany; Oslo, Norway; Vienna, Austria)

Responsibilities

Oversee best-in-class EMEA cross-TA evidence generation strategy
Establish a clear cross-TA process and operating model for Evidence Generation short- to long-term plans and EMEA Integrated Evidence Generation and Dissemination Plan (IEGP)
Lead regional IEGP process for EMEA region: train IBVT and CVT teams on responsibilities and key deliverables; organize and chair IEGP strategy (Q1) and tactics (Q2) reviews; establish prioritization for ESO EG investments; present consolidated plans and seek endorsement from relevant leadership bodies (ESLT, ELT)
Coordinate EMEA contribution to WW IEGP process: align deliverables of EMEA and WW IEGP; review and provide recommendations to optimize impact of WW IEGP for EMEA
Work with VP MAF and VP HEMAR to agree and finalize the above
Oversee communication (regionally, locally, and globally) and rollout of EMEA plans involving key stakeholders
Identify and collate with key stakeholders (ETAHs, TAMALs, GMALs, Opco TA teams) a core set of evidence deliverables and associated timelines that create value for EMEA
Incorporate competitive insights cross-TA via new CI tools (Insight Miner) in conjunction with CDS
Design and track medical and business impact of EMEA IEGP
Establish collaboration model with EMEA HEMAR team and MAF TA teams and define a clear set of roles and responsibilities
Strengthen engagement and processes with key countries to ensure their input
Identify critical priorities for key countries across EMEA and facilitate early engagement and dialogue between major EMEA markets and global decision-makers
Identify opportunities to strengthen EMEA input into core company processes, such as early CDP shaping, TPP development, regulatory filing discussions
Continually assess the need for new organizational capabilities

Skills

Key technologies and capabilities for this role

Evidence GenerationMedical AffairsStrategic PlanningMarket AccessProduct Lifecycle ManagementJanssen Pipeline

Questions & Answers

Common questions about this position

What is the location for this EMEA Medical Affairs Director role?

The role is based in EMEA with multiple possible locations including Beerse (Belgium), Breda (Netherlands), Diegem (Belgium), Espoo (Finland), Issy-les-Moulineaux (France), Madrid (Spain), Milano (Italy), Neuss (Germany), Oslo (Norway), and Vienna (Austria).

What are the key responsibilities of this position?

Key responsibilities include overseeing the EMEA cross-TA evidence generation strategy, leading the regional IEGP process by training teams and chairing reviews, coordinating EMEA contributions to the WW IEGP process, and working with VP MAF and VP HEMAR to finalize plans.

Who does this role report to?

This role reports directly to the ESO Medical Excellence Senior Director, EMEA Operational Excellence Strategy.

What is the employment type for this position?

The position is full time.

What experience or skills make a strong candidate for this role?

Strong candidates should have expertise in evidence generation strategies across the product lifecycle, experience leading cross-therapeutic area processes, and the ability to coordinate with regional and worldwide teams on IEGP plans, as inferred from the key responsibilities.

Johnson & Johnson

Healthcare products in pharmaceuticals and devices.

About Johnson & Johnson

Johnson & Johnson operates in the healthcare sector with three main areas: pharmaceuticals, medical devices, and consumer health products. In the pharmaceuticals segment, the company develops prescription drugs for various medical conditions such as cancer and infectious diseases. The medical devices segment provides products used in surgeries and other medical procedures, while the consumer health segment offers over-the-counter products, including baby care and personal health items. Johnson & Johnson generates revenue through direct sales and partnerships, and it invests significantly in research and development to create new products that meet the needs of consumers and healthcare providers. The company stands out from competitors by emphasizing diversity, equity, and inclusion in its workplace, fostering an environment where employees can share their perspectives. Its goal is to improve patient outcomes and enhance the overall health and well-being of individuals globally.

New Brunswick, New JerseyHeadquarters

1886Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

J&J faces a class action lawsuit in Australia over ineffective cold and flu medications.

Former J&J executives joining other firms could lead to increased competition.

Ongoing legal battles, like the lawsuit against Cigna, pose financial liabilities for J&J.

Differentiation

J&J operates in three segments: pharmaceuticals, medical devices, and consumer health.

The company invests heavily in R&D for innovative medical solutions and products.

J&J is committed to diversity, equity, and inclusion in its workplace culture.

Upsides

J&J's collaboration with Helsinki University Hospital focuses on value-based healthcare models.

The rise of personalized medicine offers J&J opportunities in targeted therapies.

Increased focus on digital health solutions presents expansion opportunities for J&J.

Land your dream remote job 3x faster with AI

Try Jobo Free